Looks like there gonna try to get it approved as an add on.
Related topics
Topic | Replies | Views | Activity | |
---|---|---|---|---|
AbbVie (ABBV) Falls 13% After Results for Emraclidine in Schizophrenia Did Not Meet their Primary Endpoint | 3 | 107 | November 11, 2024 | |
AbbVie to tap Vraylar messaging lessons, but also create a new position to promote key psychiatric drug from Cerevel buy | 2 | 293 | December 8, 2023 | |
AbbVie's Emraclidine: M4 Agonist Might Become Best-In-Class In Schizophrenia | 0 | 81 | October 9, 2024 | |
Emraclidine delivers positive results in phase Ib trial | 0 | 181 | December 28, 2023 | |
Emraclidine (from Cerevel Therapeutics) is an antipsychotic with a mechanism very similar to that of KarxT | 2 | 440 | April 29, 2023 |